Development and characterization of pramipexole dihydrochloride buccal films for Parkinson's disease treatment.

Development and characterization of pramipexole dihydrochloride buccal films for Parkinson's disease treatment.

Show other versions (1)

Parkinson's disease is one of the most common neurodegenerative diseases worldwide. Swallowing difficulties present a significant challenge in the treatment of Parkinson's disease patients. Our current experimental work aimed to produce and assess a buccal polymer film containing pramipexo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Krisztián Pamlényi, Bárbara Ferreira, Géza Regdon, Katalin Kristó, Bruno Sarmento
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0329142
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development and characterization of pramipexole dihydrochloride buccal films for Parkinson’s disease treatment
by: Krisztián Pamlényi, et al.
Published: (2025-01-01)

Development and Optimization of Chitosan-Ascorbate-Based Mucoadhesive Films for Buccal Delivery of Captopril
by: Krisztián Pamlényi, et al.
Published: (2025-03-01)

Study of the Effect of Temperature on the Production of Carrageenan-Based Buccal Films and Optimization of the Process Parameters
by: Katalin Kristó, et al.
Published: (2024-12-01)

Dyskinesias and Treatment with Pramipexole in Patients with Parkinson's Disease
by: John C. P. Piedad, et al.
Published: (2012-01-01)

Cutting-Edge Approaches in the Co-Amorphization Process
by: Azza A. K. Mahmoud, et al.
Published: (2025-06-01)

A Systematic Review and Meta-Analysis of the Efficacy and Safety of Rasagiline or Pramipexole in the Treatment of Early Parkinson’s Disease
by: Pauli Seppänen, et al.
Published: (2024-01-01)

Lipid-Polymer Hybrid Nanoparticles as a Smart Drug Delivery System for Peptide/Protein Delivery
by: Alharith A. A. Hassan, et al.
Published: (2025-06-01)

Minimal Clinically Important Difference in Parkinson’s Disease as Assessed in Pivotal Trials of Pramipexole Extended Release
by: Robert A. Hauser, et al.
Published: (2014-01-01)

USE OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY-STAGE PARKINSON’S DISEASE: DESCRIPTION OF A CLINICAL CASE
by: N. V. Fedorova, et al.
Published: (2014-11-01)

Twice-Daily versus Once-Daily Pramipexole Extended Release Dosage Regimens in Parkinson’s Disease
by: Ji Young Yun, et al.
Published: (2017-01-01)

Palatable Levocetirizine Dihydrochloride Solid Dispersed Fast-Dissolving Films: Formulation and In Vitro and In Vivo Characterization
by: Sana Saleh Al-Kubati, et al.
Published: (2022-01-01)

Levodopa and pramipexole combination therapy efficacy in Vietnamese patients with Parkinson’s disease: a randomized controlled trial
by: Minh Van Le, et al.
Published: (2024-03-01)

Design and Characterization of Buccal Films of Benzocaine for Mouth Ulcer
by: Jiji Jose, et al.
Published: (2021-09-01)

Efficacy and safety of levocetirizine dihydrochloride in the treatment of pediatric asthmatic diseases
by: CHENG Youde, et al.
Published: (2025-05-01)

Novel Polymorphic Patterns for Elacestrant Dihydrochloride
by: Zia Uddin Masum, et al.
Published: (2025-06-01)

Ophthalmologic Baseline Characteristics and 2-Year Ophthalmologic Safety Profile of Pramipexole IR Compared with Ropinirole IR in Patients with Early Parkinson’s Disease
by: William Seiple, et al.
Published: (2016-01-01)

Exploring the interconnected properties of cannabidiol suspensions and orodispersible films
by: Robert-Alexandru Vlad, et al.
Published: (2025-07-01)

Sapropterin dihydrochloride treatment in Turkish hyperphenylalaninemic patients under age four
by: Özlem Ünal, et al.
Published: (2015-06-01)

Synthesis, Spectral Characterization and Evaluation of Pharmacodynamic Activity of Copper and Nickel Complexes of Ethambutol Dihydrochloride
by: M. Mathrusri Annapurna, et al.
Published: (2006-01-01)

Vertigo in therapeutic practice. Betahistine dihydrochloride potential
by: O. D. Ostroumova
Published: (1970-01-01)

A novel opioid/pramipexole combination treatment for the management of acute pain: a pilot study
by: Cara Girardi, et al.
Published: (2024-09-01)

Dopamine Dysregulation Syndrome in Parkinson’s Disease Patients with Unsatisfactory Switching from Immediate to Extended Release Pramipexole: A Further Clue to Incentive Sensitization Mechanisms?
by: Paolo Solla, et al.
Published: (2013-01-01)

Drug Delivery System Using a Buccal Film
by: Zainab Thabit Salih, et al.
Published: (2023-08-01)

The role of betahistine dihydrochloride in the treatment of peripheral vestibular syndrome in dogs – study of 3 cases
by: Raluca Mihaela Turbatu, et al.
Published: (2019-12-01)

UV Spectrophotometric Estimation of Levoceterizine Dihydrochloride in Bulk and Dosage Form
by: P. Mamatha, et al.
Published: (2010-01-01)

Prospective Study to Assess Long‐Term Outcomes of Chelator‐Based Treatment With Trientine Dihydrochloride in Patients With Wilson Disease
by: Isabelle Mohr, et al.
Published: (2025-03-01)

Long-term risk of malignancies in persons with ischemic heart disease treated with trimetazidine dihydrochloride
by: Yuen-Ting Cheng, et al.
Published: (2025-03-01)

The use of chitosan in the preparation of bioadhesive buccal films: Film-forming ability and sustaining ibuprofen release
by: Fadia Mussa, et al.
Published: (2021-07-01)

Design, development, and optimization of mucoadhesive buccal films of ganaxolone for enhanced bioavailability
by: Onkar Pawar, et al.
Published: (2025-04-01)

Pramipexole in addition to mood stabilisers for treatment-resistant bipolar depression: the PAX-BD randomised double-blind placebo-controlled trial
by: Hamish McAllister-Williams, et al.
Published: (2025-05-01)

Taste-masking assessment of orally disintegrating tablets and lyophilisates with cetirizine dihydrochloride microparticles
by: Aleksandra Amelian, et al.
Published: (2017-12-01)

Restless Legs Syndrome Patients with Early Onset Disease or a Relevant Family History Associated with Pramipexole Ineffectiveness but Not Pregabalin
by: Ying M, et al.
Published: (2025-07-01)

Regional cerebral blood flow in a patient with restless legs syndrome exhibiting pramipexole‐induced hypersexuality
by: Toshiki Obata, et al.
Published: (2025-06-01)

Design and Evaluation of Instant Release Buccal Films of Empagliflozin: A Statistical Approach
by: Ahmad Salawi, et al.
Published: (2025-05-01)

Case Report: Syndrome of inappropriate antidiuretic hormone secretion induced by pramipexole: a case report and literature review
by: Ke-Qian Chen, et al.
Published: (2025-08-01)

Quality by Design-Based Methodology for Development of Titanate Nanotubes Specified for Pharmaceutical Applications Based on Risk Assessment and Artificial Neural Network Modeling
by: Ranim Saker, et al.
Published: (2025-01-01)

Characteristics, preparation and applicability in oral delivery systems of cellulose ether–based buccal films
by: Hong Cheng, et al.
Published: (2025-12-01)

Influence of betahistidine dihydrochloride and antihypertensive medications on quality of life in patients with stable arterial hypertension and vertigo
by: G. F. Andreeva, et al.
Published: (2005-06-01)

Evaluation of Micronucleus in Buccal Mucosa Samples as a Potential Biomarker for Early Diagnosis of Parkinson’s Disease: A Cross-sectional Study
by: Disha K Davis, et al.
Published: (2025-05-01)

Delayed buccal fat pad herniation: An unusual complication of buccal flap in cleft surgery
by: Puneet Tuli, et al.
Published: (2009-01-01)